Monotherapy interferons. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

Cell Line L Cells (Cell Line)Cells, Cultured Macrophages Spleen T-Lymphocytes Fibroblasts Leukocytes, Mononuclear Killer Cells, Natural Leukocytes CD4-Positive T-Lymphocytes Dendritic Cells Lymphocytes Cell Line, Tumor CD8-Positive T-Lymphocytes Th1 Cells Liver Vero Cells Monocytes Lung Tumor Cells, Cultured HeLa Cells Kidney

Organisms16

Newcastle disease virus Vesicular stomatitis Indiana virus Hepacivirus Encephalomyocarditis virus Mice, Inbred C57BL Mice, Inbred BALB C Parainfluenza Virus 1, Human Mice, Knockout Sendai virus Mengovirus Hepatitis B virus HIV-1 Viruses Cercopithecus aethiops Mice, Inbred C3H Mycobacterium tuberculosis

Diseases20

Hepatitis C, Chronic Epilepsy Hepatitis C Recurrence Hepatitis B, Chronic Epilepsies, Partial Disease Progression Fever Virus Diseases Disease Models, Animal HIV Infections Arthritis, Rheumatoid Neutropenia Diabetes Mellitus, Type 2 Hypertension Melanoma Neoplasm Metastasis Bacterial Infections Epilepsy, Generalized Hepatitis B

Chemicals and Drugs126

Interferons Interferon Type I Interferon-alpha Interferon Inducers Receptors, Interferon Interferon-gamma Interferon-beta Interferon Regulatory Factor-3 Interferon Regulatory Factor-1 Antiviral Agents Interferon Regulatory Factors Receptor, Interferon alpha-beta Interferon Regulatory Factor-7 Ribavirin Recombinant Proteins Poly I-C Interferon Regulatory Factor-2 Anticonvulsants Carbamazepine Polyethylene Glycols STAT1 Transcription Factor 2',5'-Oligoadenylate Synthetase Drug Combinations Cytokines Valproic Acid Antineoplastic Agents Piracetam Antibodies, Monoclonal Antibodies, Monoclonal, Humanized STAT2 Transcription Factor RNA, Viral Azetidines Interferon-Stimulated Gene Factor 3 Antihypertensive Agents RNA, Messenger Triazines Lamivudine Interferon-Stimulated Gene Factor 3, gamma Subunit Myxovirus Resistance Proteins Hydrochlorothiazide Metformin Immunosuppressive Agents Tumor Necrosis Factor-alpha Antirheumatic Agents Hypoglycemic Agents Organophosphonates RNA, Double-Stranded Methotrexate Lopinavir Artemisinins Immunologic Factors Sulfonylurea Compounds Viral Nonstructural Proteins Amlodipine Ritonavir Anti-Bacterial Agents Antimanic Agents DNA-Binding Proteins Interleukin-12 Deoxycytidine Interleukin-4 Adenine Alanine Transaminase Triazoles Pyrroles DEAD-box RNA Helicases Sulfonamides Tilorone Anticholesteremic Agents Adamantane Viral Proteins Lithium Compounds eIF-2 Kinase Tacrolimus Antimalarials Phenytoin Interleukins Anti-HIV Agents Hepatitis B e Antigens Tosyl Compounds Tetrazoles Cilastatin Interleukin-2 Chemokine CXCL10 Quinolines Antimetabolites, Antineoplastic Antipsychotic Agents Prostaglandins F, Synthetic Aza Compounds Quinazolines Dactinomycin Pyrimidinones Interleukin-10 Trans-Activators Pyrimidines Zidovudine Transcription Factors Sulfasalazine Isoxazoles Oxonic Acid Dipeptidyl-Peptidase IV Inhibitors Lipopolysaccharides Toll-Like Receptor 3 TYK2 Kinase Nitriles Fluorouracil Cycloheximide Amikacin Adjuvants, Immunologic Angiotensin-Converting Enzyme Inhibitors Ceftazidime Angiotensin II Type 1 Receptor Blockers Angiogenesis Inhibitors Cyclosporine Hemoglobin A, Glycosylated Pyridones Reverse Transcriptase Inhibitors Janus Kinase 1 Thiazolidinediones Carboxymethylcellulose Sodium Phosphoproteins Heptanoic Acids Aminoglycosides DNA, Viral Piperazines HIV Protease Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment36

Drug Therapy, Combination Treatment Outcome Drug Administration Schedule Double-Blind Method Treatment Failure Viral Load Prospective Studies Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Administration, Oral Randomized Controlled Trials as Topic Follow-Up Studies Clinical Trials as Topic Survival Analysis Disease Models, Animal Lymphocyte Activation Disease-Free Survival Injections, Subcutaneous Cytopathogenic Effect, Viral Drug Evaluation Flow Cytometry Reverse Transcriptase Polymerase Chain Reaction Severity of Illness Index Combined Modality Therapy Culture Techniques Drug Substitution Remission Induction Clinical Trials, Phase II as Topic Retreatment Viral Plaque Assay Pilot Projects Liver Transplantation Survival Rate Enzyme-Linked Immunosorbent Assay Polypharmacy Transfection

Phenomena and Processes34

Time Factors Virus Replication Dose-Response Relationship, Drug Drug Synergism Viral Load Immunity, Innate Signal Transduction Gene Expression Regulation RNA, Double-Stranded Viral Interference Drug Resistance, Viral Base Sequence Drug Resistance Lymphocyte Activation Transcription, Genetic Mutation Cytopathogenic Effect, Viral Genotype Gene Expression Cell Division Promoter Regions, Genetic Macrophage Activation Immune Evasion Immunity, Cellular Drug Interactions Cytotoxicity, Immunologic Amino Acid Sequence Apoptosis Kinetics Phosphorylation Graft Rejection Host-Pathogen Interactions Transfection Drug Resistance, Neoplasm

Technology, Industry, Agriculture1

Polyethylene Glycols

Information Science4

Molecular Sequence Data Base Sequence Survival Rate Amino Acid Sequence

Health Care16

Treatment Outcome Double-Blind Method Treatment Failure Prospective Studies Retrospective Studies Randomized Controlled Trials as Topic Follow-Up Studies Clinical Trials as Topic Survival Analysis Disease-Free Survival Severity of Illness Index Drug Substitution Clinical Trials, Phase II as Topic Pilot Projects Survival Rate Cost-Benefit Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care

Interferons Interferon Type I Interferon-alpha Interferon Inducers Drug Therapy, Combination Receptors, Interferon Interferon-gamma Interferon-beta Interferon Regulatory Factor-3 Interferon Regulatory Factor-1 Antiviral Agents Interferon Regulatory Factors Receptor, Interferon alpha-beta Treatment Outcome Interferon Regulatory Factor-7 Ribavirin Recombinant Proteins Poly I-C Interferon Regulatory Factor-2 Newcastle disease virus Hepatitis C, Chronic Anticonvulsants Carbamazepine Polyethylene Glycols Drug Administration Schedule Cell Line Vesicular stomatitis Indiana virus STAT1 Transcription Factor 2',5'-Oligoadenylate Synthetase L Cells (Cell Line)Time Factors Cells, Cultured Drug Combinations Cytokines Hepacivirus Virus Replication Double-Blind Method Valproic Acid Dose-Response Relationship, Drug Antineoplastic Agents Piracetam Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Encephalomyocarditis virus Mice, Inbred C57BL STAT2 Transcription Factor RNA, Viral Drug Synergism Treatment Failure Mice, Inbred BALB C Epilepsy Azetidines Interferon-Stimulated Gene Factor 3 Antihypertensive Agents Viral Load Immunity, Innate RNA, Messenger Triazines Hepatitis C Lamivudine Interferon-Stimulated Gene Factor 3, gamma Subunit Myxovirus Resistance Proteins Signal Transduction Hydrochlorothiazide Metformin Prospective Studies Retrospective Studies Gene Expression Regulation Immunosuppressive Agents Recurrence Tumor Necrosis Factor-alpha Antirheumatic Agents Macrophages Spleen Hepatitis B, Chronic T-Lymphocytes Hypoglycemic Agents Antineoplastic Combined Chemotherapy Protocols Organophosphonates Administration, Oral Epilepsies, Partial Molecular Sequence Data Parainfluenza Virus 1, Human RNA, Double-Stranded Randomized Controlled Trials as Topic Methotrexate Lopinavir Artemisinins Immunologic Factors Fibroblasts Sulfonylurea Compounds Viral Interference Viral Nonstructural Proteins Leukocytes, Mononuclear Follow-Up Studies Drug Resistance, Viral Disease Progression Amlodipine Killer Cells, Natural Ritonavir

No FAQ available that match "monotherapy interferons"